Why generic AI content tools can't check for off-label claims

Ask a general-purpose AI writing tool to draft copy about a medication, and it will produce something fluent, persuasive, and very possibly wrong in a way that matters. Not wrong because the model is bad at writing. Wrong because it has no way to know what your product's approved label actually says.

What it is

A generic AI model is trained on a broad mix of public text: articles, forums, marketing copy from across the internet, some of it about your product category, none of it necessarily reflecting your specific product's approved indication, dosing, or population. When asked to write a benefit claim, it will produce something that sounds medically plausible, because plausible-sounding medical language is exactly what it learned to generate. It has no built-in concept of "approved for this population, not that one," because approval status isn't something that shows up as a pattern in general text the way grammar or tone does.

Why it matters

An off-label claim doesn't require the model to say anything false. A statement can be entirely accurate in a general medical sense (a drug class does relieve a symptom, in general) and still be off-label for a specific product, because that product's approval doesn't cover that symptom, that population, or that comparison. A generic model has no mechanism to check a specific claim against a specific label, because it was never given the label in the first place. It's answering "does this sound right" when the actual question is "is this approved."

That gap is invisible in the output. Copy that implies an off-label claim reads exactly like copy that doesn't, which is why catching it usually falls entirely on a human reviewer working after the fact, rather than on anything built into the generation step itself.

How it actually works

The difference between a generic tool and one built for regulated marketing is what the model is actually checked against, not how well it writes:

• No approved-claim set: a generic model has nothing analogous to a brand dossier, a first-party list of the claims a specific product is actually cleared to make. Without that list, there's no claim to check a draft against.
• No claim-checking step: even a model that could technically detect medical language has no built-in step that compares a draft's implied claims to an approved set and blocks the ones that don't match. Claim linking has to exist as a distinct check, not an assumed side effect of good writing.
• No population or label awareness: a generic model doesn't distinguish an approved indication from a broader disease-state discussion, so a claim can be off-label by scope (right symptom, wrong population, or wrong severity) without the model treating it any differently from an on-label one.

SwishX's reasoning pipeline exists specifically to close this gap: every implied claim is checked against an account's actual brand dossier at two separate points, before and after generation, rather than relying on the model's general medical knowledge to self-police.

Related reading

• What is an AI reasoning pipeline, in a regulated industry?
• What does on-label and off-label actually restrict?
• Brand Dossier